Alpenglow Biosciences Expands Advisory Board with Two Esteemed Industry Leaders
Alpenglow Biosciences, a pioneer in advanced 3D spatial tissue imaging, the next evolution of static digital pathology, is pleased to announce the appointment of Blandine Merino MS and Mike Rice to its Advisory Board. Their extensive expertise in next-generation sequencing, digital pathology, AI-driven cancer detection, manufacturing, and life science tools will be instrumental in expanding Alpenglow’s impact in precision medicine.
Alpenglow Biosciences Unveils LUMI: A Revolutionary Imaging Interface at ABRF 2025
Alpenglow Biosciences, a leader in 3D spatial biology, proudly announces the launch of LUMI, an intuitive user interface designed to integrate smart microscopy into the light-sheet workflow. Attendees of the Association of Biomolecular Resource Facilities (ABRF) 2025 Annual Meeting will get an exclusive first look at LUMI’s capabilities.
Alpenglow Biosciences and Partners Secure a Total of $24M for Development of Alpenglow’s 3D Spatial Pathology Platform
Alpenglow Biosciences, a leading 3D spatial biology company, was recently awarded contracts from Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health (NIH) and secured additional investment to further its clinical product development.
